The Association of Helicobacter pylori Infection and Nonsteroidal Anti-Inflammatory Drugs in Peptic Ulcer Disease

BACKGROUND AND AIM: Peptic ulcer disease (PUD) affects 10% of the world population. Helicobacter pylori infection and the use of a nonsteroidal anti-inflammatory drug (NSAID) are the principal factors associated with PUD. The aim of the present study was to evaluate a cohort of patients with PUD and...

Full description

Bibliographic Details
Main Authors: Juan Carlos Zapata-Colindres, Sergio Zepeda-Gómez, Aldo Montaño-Loza, Edgar Vázquez-Ballesteros, José de Jesús Villalobos, Francisco Valdovinos-Andraca
Format: Article
Language:English
Published: Hindawi Limited 2006-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2006/175217
id doaj-9c94928a915d433fae053c6a9c207c60
record_format Article
spelling doaj-9c94928a915d433fae053c6a9c207c602020-11-24T23:29:23ZengHindawi LimitedCanadian Journal of Gastroenterology0835-79002006-01-0120427728010.1155/2006/175217The Association of Helicobacter pylori Infection and Nonsteroidal Anti-Inflammatory Drugs in Peptic Ulcer DiseaseJuan Carlos Zapata-Colindres0Sergio Zepeda-Gómez1Aldo Montaño-Loza2Edgar Vázquez-Ballesteros3José de Jesús Villalobos4Francisco Valdovinos-Andraca5Departments of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, MexicoEndoscopy, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, MexicoDepartments of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, MexicoDepartments of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, MexicoDepartments of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, MexicoEndoscopy, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, MexicoBACKGROUND AND AIM: Peptic ulcer disease (PUD) affects 10% of the world population. Helicobacter pylori infection and the use of a nonsteroidal anti-inflammatory drug (NSAID) are the principal factors associated with PUD. The aim of the present study was to evaluate a cohort of patients with PUD and determine the association between H pylori infection and NSAID use.http://dx.doi.org/10.1155/2006/175217
collection DOAJ
language English
format Article
sources DOAJ
author Juan Carlos Zapata-Colindres
Sergio Zepeda-Gómez
Aldo Montaño-Loza
Edgar Vázquez-Ballesteros
José de Jesús Villalobos
Francisco Valdovinos-Andraca
spellingShingle Juan Carlos Zapata-Colindres
Sergio Zepeda-Gómez
Aldo Montaño-Loza
Edgar Vázquez-Ballesteros
José de Jesús Villalobos
Francisco Valdovinos-Andraca
The Association of Helicobacter pylori Infection and Nonsteroidal Anti-Inflammatory Drugs in Peptic Ulcer Disease
Canadian Journal of Gastroenterology
author_facet Juan Carlos Zapata-Colindres
Sergio Zepeda-Gómez
Aldo Montaño-Loza
Edgar Vázquez-Ballesteros
José de Jesús Villalobos
Francisco Valdovinos-Andraca
author_sort Juan Carlos Zapata-Colindres
title The Association of Helicobacter pylori Infection and Nonsteroidal Anti-Inflammatory Drugs in Peptic Ulcer Disease
title_short The Association of Helicobacter pylori Infection and Nonsteroidal Anti-Inflammatory Drugs in Peptic Ulcer Disease
title_full The Association of Helicobacter pylori Infection and Nonsteroidal Anti-Inflammatory Drugs in Peptic Ulcer Disease
title_fullStr The Association of Helicobacter pylori Infection and Nonsteroidal Anti-Inflammatory Drugs in Peptic Ulcer Disease
title_full_unstemmed The Association of Helicobacter pylori Infection and Nonsteroidal Anti-Inflammatory Drugs in Peptic Ulcer Disease
title_sort association of helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease
publisher Hindawi Limited
series Canadian Journal of Gastroenterology
issn 0835-7900
publishDate 2006-01-01
description BACKGROUND AND AIM: Peptic ulcer disease (PUD) affects 10% of the world population. Helicobacter pylori infection and the use of a nonsteroidal anti-inflammatory drug (NSAID) are the principal factors associated with PUD. The aim of the present study was to evaluate a cohort of patients with PUD and determine the association between H pylori infection and NSAID use.
url http://dx.doi.org/10.1155/2006/175217
work_keys_str_mv AT juancarloszapatacolindres theassociationofhelicobacterpyloriinfectionandnonsteroidalantiinflammatorydrugsinpepticulcerdisease
AT sergiozepedagomez theassociationofhelicobacterpyloriinfectionandnonsteroidalantiinflammatorydrugsinpepticulcerdisease
AT aldomontanoloza theassociationofhelicobacterpyloriinfectionandnonsteroidalantiinflammatorydrugsinpepticulcerdisease
AT edgarvazquezballesteros theassociationofhelicobacterpyloriinfectionandnonsteroidalantiinflammatorydrugsinpepticulcerdisease
AT josedejesusvillalobos theassociationofhelicobacterpyloriinfectionandnonsteroidalantiinflammatorydrugsinpepticulcerdisease
AT franciscovaldovinosandraca theassociationofhelicobacterpyloriinfectionandnonsteroidalantiinflammatorydrugsinpepticulcerdisease
AT juancarloszapatacolindres associationofhelicobacterpyloriinfectionandnonsteroidalantiinflammatorydrugsinpepticulcerdisease
AT sergiozepedagomez associationofhelicobacterpyloriinfectionandnonsteroidalantiinflammatorydrugsinpepticulcerdisease
AT aldomontanoloza associationofhelicobacterpyloriinfectionandnonsteroidalantiinflammatorydrugsinpepticulcerdisease
AT edgarvazquezballesteros associationofhelicobacterpyloriinfectionandnonsteroidalantiinflammatorydrugsinpepticulcerdisease
AT josedejesusvillalobos associationofhelicobacterpyloriinfectionandnonsteroidalantiinflammatorydrugsinpepticulcerdisease
AT franciscovaldovinosandraca associationofhelicobacterpyloriinfectionandnonsteroidalantiinflammatorydrugsinpepticulcerdisease
_version_ 1725545928462434304